Pharmaceuticals

Projected Growth of the Global Darbepoetin Alfa (Aranesp) Market to Reach $7.37 Billion by 2029

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the darbepoetin alfa (aranesp) market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Darbepoetin Alfa (Aranesp) Market By The End Of 2029?

The darbepoetin alfa (aranesp) market has experienced consistent expansion in recent years. This market is anticipated to increase from $5.81 billion in 2024 to $6.06 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.2%. The historical expansion can be linked to improvements in anemia treatment, the need for erythropoiesis-stimulating agents (ESAs), developments in biopharmaceutical innovation, broad clinical acceptance, and enhanced patient results.

The darbepoetin alfa (aranesp) market is anticipated to experience robust expansion in the coming years. It is predicted to reach ” $7.37 billion in 2029, progressing at a compound annual growth rate (CAGR) of 5.0%. This growth throughout the forecast period is driven by factors such as healthcare reimbursement policies, enhanced awareness and education, improvements in healthcare infrastructure, increasing demands for renal care, and an aging population. Significant trends during this period are expected to include global market penetration, the integration of digital health, personalized treatment approaches, the adoption of biosimilars, and the development of long-acting formulations.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12171&type=smp

Which Business Drivers Are Underpinning The Growth Of The Darbepoetin Alfa (Aranesp) Market?

The rising occurrence of chronic illnesses is anticipated to boost the expansion of the darbepoetin alfa market in the future. A chronic disease refers to a type of illness that persists for at least three months and may worsen over time. Darbepoetin alfa finds application in managing diverse chronic conditions, particularly in reversing anemia caused by chemotherapy in cancer patients. As an illustration, data from June 2024, provided by the Australian Institute of Health and Welfare, an Australia-based statutory authority of the Australian Government, revealed that chronic conditions led to 171,500 deaths in 2022, accounting for 90% of all deaths, at a rate of 659 per 100,000 population. The age-standardized mortality rate attributed to chronic conditions decreased to 448 per 100,000 in 2020 before climbing to 459 in 2021 and 490 in 2022. Consequently, the heightened prevalence of chronic diseases is fueling the expansion of the darbepoetin alfa market.

What Are The Principal Segment Types In The Darbepoetin Alfa (Aranesp) Market?

The darbepoetin alfa (aranesp) market covered in this report is segmented –

1) By Type: Epogen, Procrit, Aranesp, Other Types

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

3) By Application: Patients With Chronic Kidney Disease, Patients With Cancer, Other Applications

Subsegments:

1) By Epogen: Standard Formulations, Enhanced Formulations

2) By Procrit: Standard Formulations, Biosimilars

3) By Aranesp: Single-Dose Vials, Multi-Dose Vials

4) By Other Types: Combination Therapies, Alternative Erythropoiesis-Stimulating Agents

How Are Industry Trends Steering The Expansion Of The Darbepoetin Alfa (Aranesp) Market?

Product innovations are a significant development gaining traction within the darbepoetin alfa market. Major companies operating in the darbepoetin alfa market are implementing new technologies to sustain their market position. For instance, in February 2023, GlaxoSmithKline. Ltd., a UK-based pharmaceutical and biotechnology company, introduced Jesduvroq (daprodustat), which was approved by the US Food and Drug Administration (FDA), a US-based government agency. Daprodustat, identified as recombinant human erythropoietin (rhEPO, darbepoetin alfa or epoetin alfa), functions as an oral hypoxia-inducible factor prolyl hydroxylase inhibitor and is prescribed as a once daily treatment for anemia caused by chronic kidney disease (CKD) in individuals who have undergone dialysis for a minimum of four months.

Which Companies Are Contributing Significantly To The Darbepoetin Alfa (Aranesp) Market Growth?

Major companies operating in the darbepoetin alfa (aranesp) market include Johnson & Johnson, Amgen Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Serum Institute of India Pvt. Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Biocon Ltd., Reliance Life Sciences, Torrent Pharmaceuticals Ltd., 3SBio Inc., Cadila Healthcare Ltd., Dong-A ST Co. Ltd., Chong Kun Dang Holdings, Hetero Drugs Ltd., Intas Pharmaceuticals Ltd., Avesthagen Pharma, Stada Arzneimittel AG, Ranbaxy Laboratories Ltd., Sandoz International GmbH, Shandong Kexing Bioproducts Co. Ltd., Kyowa Kirin Co. Ltd., Polifarma S.p.A.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/darbepoetin-alfa-aranesp-global-market-report

Which Region Offers The Most Opportunity For Darbepoetin Alfa (Aranesp) Market Expansion?

North America was the largest region in the darbepoetin alfa (Aranesp) market in 2024. The regions covered in the darbepoetin alfa (Aranesp) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=12171&type=smp

Browse Through More Reports Similar to the Global Darbepoetin Alfa (Aranesp) Market 2025, By The Business Research Company

Probiotics Food And Cosmetics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/probiotics-food-and-cosmetics-global-market-report

Waterless Cosmetics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/waterless-cosmetics-global-market-report

Mineral Cosmetics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/mineral-cosmetics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795